Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 20/20 | 0.64 |
| ▸ | CDK6 | Q00534 | 20/20 | 0.64 |
| ▸ | CSF1R | P07333 | 15/20 | 0.64 |
| ▸ | CCNA2 | P20248 | 4/20 | 0.53 |
| ▸ | CDK2 | P24941 | 4/20 | 0.53 |
| ▸ | CCNK | O75909 | 2/20 | 0.53 |
| ▸ | CDK7 | P50613 | 2/20 | 0.53 |
| ▸ | CDK9 | P50750 | 2/20 | 0.53 |
| ▸ | CCNH | P51946 | 2/20 | 0.53 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.53 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.53 |
| ▸ | PIK3CD | O00329 | 5/20 | 0.50 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24632646 | 0.86 | CDK4 (0.63) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL24632938 | 0.85 | CDK6 (0.74) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL24632772 | 0.83 | CDK4 (0.48) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL24632917 | 0.82 | CDK4 (0.64) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL24632916 | 0.82 | CDK4 (0.64) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL24632690 | 0.81 | CDK4 (0.70) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL24632773 | 0.81 | CDK6 (0.66) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL24632790 | 0.81 | CDK4 (0.66) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL24632788 | 0.81 | CDK6 (0.65) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL24632914 | 0.80 | CDK4 (0.65) | CDK4CDK6CSF1RCCNA2CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022236256-A1 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | NUVATION BIO INC. (US) | 2022-11-10 | — | — | WO | disclosed |